PRE-CONFERENCE - Wednesday, 18 September 


ZETA Meeting room of the Radisson Blu Hotel "Lietuva"

Free registration for all registered participants of the 5th CEE Meeting 

 15:30Registration and sandwich buffet

Welcome and Introduction
Saye Khoo, PhD, University of Liverpool, United Kingdom
Saulius Caplinskas, MD, PhD, ULAC, Lithuania

 16:05Khoo, Saye 2016 120x160Introductory lecture + questions
Saye Khoo, MD, PhD, University of Liverpool, United Kingdom

Fiona, Marra PhD

Mini Lecture - HIV/HCV coinfection
Fiona Marra, University of Liverpool, United Kingdom

 17:05Coffee break

Milosz Parczewski, MD, PhD

Case 1:  Multimorbidity + questions and discussion
Milosz Parczewski, MD, PhD, Pomeranian Medical University, Poland

 17:55Anca Streinu-Cercel, MD, PhDCase 2:  Woman with HBV/HCV coinfection + questions and discussion

Anca Streinu-Cercel, MD, PhD, Carol Davila University of Medicine and Pharmacy, Romania


Ales Chrdle photo (002)Case 3: From Chemsex to intensive care, then back to Chemsex? + questions and discussion
Aleš Chrdle, MD, České Budějovice Hospital, Czech Republic

 18:55Closing remarks
  19:00              DINNER FOR ALL PARTICIPANTS 
   The Liverpool Course is supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.



Day 1 - Thursday, 19 September 2019

 08:45 Opening of the Workshop 
 Session 1: Epidemiology of HIV and hepatitis in the CEE countries 

Milosz Parczewski, MD, PhD

Epidemiology of viral hepatitis infection and treatment in CEE countries
Milosz Parczewski, MD, PhD, Pomeranian Medical University, Sczecin, Poland


Epidemiology of HIV infection and treatment in CEE countries
Anca Streinu-Cercel, MD, PhD, National Institute of Infectious Diseases Matei Bals, Romania

 10:00Ivanova, Elena 2018Feasibility and acceptability of HCV self-testing
Elena Ivanova, MD, PhD, FIND (Foundation for Innovative New Diagnostics), Geneva, Switzerland
 10:30 Coffee break and poster viewing 
 Session 2: Access to care

EECA: Are we lagging behind?
Sergey Golovin, ITPCru, St. Petersburg, Russia


Access to quality assured  (WHO prequalified) generic medicines in the region
Liudmyla Maistat, Medicines Patent Pool, Geneva, Switzerland


Mojca Maticic, MD, PhD

Access to key populations
Mojca Maticic, MD, PhD, University of Ljubljana, Slovenia

 11:30Round Table Discussion 
 Session 3: HIV and Hepatitis co-infection

Management of HIV/HCV co-infection in Young Women
Vadim Rassokhin, MD, 1st St. Petersburg State Medical University "Acad. I.P. Pavlov", St. Petersburg, Russia

  Abstract-Driven Presentations 
 12:00 Door-to-door hepatitis C testing in three large cities of Georgia: A pilot study
Maia Butsashvili, Georgia
 12:10The prevalence of mutations of the Hepatitis C virus, associated with drug resistance to inhibitors of protein NS5A among patients of the republic of Belarus
Elena Gasich, Belarus
 12:30Group Picture and Lunch 
 13:30Industry-sponsored symposium 
 Session 4: PrEP

PrEP and STI testing in CEE: What are the barriers, what works?
Milosz Parczewski, MD, PhD, Pomeranian Medical University, Sczecin, Poland

  Abstract-driven presentations 
 15:00Persistence on HIV pre-exposure prophylaxis medication: A challenge in pre-exposure prophylaxis (PrEP) program in Georgia
Ekaterine Karkashadze, Georgia
 15:10Virological efficacy of first-line regimens, resistance profile and factors influencing adherence to ART in clinical practice in Ukraine
Tetiana Kyrychenko, Ukraine
 15:30 Coffee Break and Poster Viewing 
 16:00Industry-sponsored symposium 
 Session 5: Linkage to care and management of treatment failure in HIV

Switching to second line HIV therapy
Pavel Khaykin, MD, MainFachArzt, Frankfurt, Germany


Raben, DortheIntegrated testing for HIV, hepatitis, and STIs
Dorthe Raben, MSc, CHIP, Copenhagen, Denmark

 18:15End of Day 1
Welcome Reception and Poster Viewing
 19:30 Workshop Dinner

Day 2 - Friday, 20 September 2019

 Session 6: HIV and tuberculosis co-infection
 9:00Management of TB and HIV infection
Daria Podlekareva, MD 
University of Copenhagen, Copenhagen, Denmark

The challenging TB case: clinical, virological and pharmacological considerations
Jonathan Schapiro, MD, Sheba Medical Centre, Tel Aviv, Israel

 9:50 Discussion 

Abstract-Driven Presentations

 10:00 Epidemiology of HIV in the Baltic countries (Estonia, Latvia, Lithuania)
Saulius Čaplinskas, Lithuania
 10:10 Uptake and outcomes of dolutegravir based antiretroviral therapy in Georgia
Nino Rukhadze, Georgia
 10:20 The new tendencies in HIV and HCV epidemics in central region of Ukraine
Tetiana Koval, Ukraine
 10:30Coffee Break and Poster Viewing 
 Session 7: Abstract-driven presentations
 11:00 Management of Hepatitis C in primary healthcare in the country of Georgia
Akaki Abutidze, Georgia
 11:10 HCV prevalence and associated factors among people who inject drugs (PWID): Baseline results of Georgian PWID cohort study
Ketevan Shermadini, Georgia
 11:20 Diversity of HIV-1 subtypes in Russia 2009-2019
Konstantin Gromov, Russia
 11:30 Outcomes for hepatitis B vaccination among HIV-infected adults in Georgia
Shorena Dvali, Georgia
 11:40 Epidemiology of hepatitis B viral infection in the republic of Belarus
Viktar Mitsura< Belarus
 11:50 Implementation of the State Program on elimination of viral hepatitis C in Ukraine: achievements and challenges
Kristyna Pronyuk, Ukraine
 12:00 High level of integrase strand transfer inhibitors drug resistance mutations in INSTIs failed HIV-1 CRF06_cpx infected patients in Estonia
Merit Pauskar
 12:00 Lunch 
 Session 8: Hot topics in HIV and hepatitis
 13:00Treatment of Hepatitis B in Ukraine: What are the remaining challenges?
Olga Golubovska, MD, PhDBogomolets National Medical University, Kyiv, Ukraine

Carolynne, Schwarze-Zander, MD

Vaccinations for HIV patients: which vaccinations when and how? Carolynne Schwarze-Zander, MD, University of Bonn, Bonn, Germany


Ligita JančorienėHIV/HCV Co-Infection: Influence on risk for cancer and cardiovascular events, and impact of successful HCV cure 
Ligita Jancoriene, MD, PhD, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania


 Jürgen Rockstroh, MDThe acute HCV Epidemic in MSM: What did we learn so far?
Juergen Rockstroh, MD, University of Bonn, Bonn, Germany

 14:40 Closing remarks 


Elena Ivanova